Successful treatment of oral potentially malignant lesions with ruxolitinib in STAT3 gain-of-function disease.

Ciara Mulvihill Kirsten Fitzgerald Esther O'Regan Claire M Healy Timothy Ronan Leahy

Oral Oncol

Department of Paediatric Immunology and Infectious Diseases, Children's Health Ireland at Crumlin, Dublin, Ireland; Department of Paediatrics, School of Medicine, University of Dublin, Trinity College, Dublin, Ireland.

Published: September 2022

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.oraloncology.2022.106015	DOI Listing

Publication Analysis

Top Keywords

successful treatment

treatment oral

oral malignant

malignant lesions

lesions ruxolitinib

ruxolitinib stat3

stat3 gain-of-function

gain-of-function disease

successful

oral

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!